415 Capital is a venture capital firm based in Munich, Germany, specializing in breakthrough medical innovations. With over 30 years of experience, they focus on addressing unmet patient needs in chronic diseases, particularly in cardio and neurovascular disorders.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
415 Capital is a venture capital firm based in Munich, Germany, that specializes in investing in breakthrough and life-saving medical innovations. Founded over 30 years ago, the firm focuses on addressing large unmet patient needs in chronic diseases, particularly in cardio and neurovascular disorders, which are leading causes of death and significant cost drivers in global healthcare systems. The firm invests in medical technologies at clinical through commercial stages, primarily in Europe, Israel, and North America, typically between €5-15 million per company. Notable portfolio companies include Endovascular Engineering, Laza Medical, and Supira Medical, among others. The firm has a history of successful exits, including Vesper Medical and Intact Vascular.
The firm invests in medical technologies at clinical through commercial stages, primarily in Europe, Israel, and North America. 415 Capital typically invests between €5-15 million per company, focusing on sectors such as structural heart disease, heart failure, neurovascular disease, and medical robotics.
415 Capital adds value to its portfolio companies by leveraging its extensive industry expertise and network to support the development and commercialization of innovative medical technologies. The firm provides strategic guidance, operational support, and access to key industry contacts to help portfolio companies succeed.
415 Capital focuses on medical technologies at clinical through commercial stages, specifically in sectors like structural heart disease and neurovascular conditions. They typically invest between €5-15 million per company.
Founders can submit their business plans through the contact page on their website at 415capital.com/contact/.
415 Capital specializes exclusively in medical technologies, addressing significant unmet patient needs in chronic diseases. Their extensive expertise in the healthcare sector enhances their portfolio companies' clinical development and commercialization efforts.
The firm invests primarily in North America and Europe, with a focus on companies that are developing innovative medical technologies.
415 Capital adds value to its portfolio companies by leveraging its extensive expertise in medical technologies and its network within the healthcare industry to support clinical development and commercialization efforts.
415 Capital typically invests between €5-15 million per company, allowing them to support startups at various stages of development.
Organizations that do similar work to 415 Capital.
InvestorDeerfield Management is a New York City-based investment management firm specializing in healthcare investments, managing over $15 billion in assets across more than 200 companies. The firm focuses on both public and private investments in sectors such as biotechnology, medical devices, and digital health.
InvestorAccelerating life sciences innovation in Massachusetts.
InvestorTransforming healthcare through strategic investments.
InvestorBessemer Venture Partners is a venture capital firm based in Redwood City, California, with additional offices in major cities across the U.S. and internationally. The firm invests in a wide range of sectors, supporting entrepreneurs from early-stage startups to growth-oriented businesses.
Superscout Pro
Is this page right?Reviewed · How the research works